ImmuneOncia Therapeutics Inc.

 

About ImmuneOncia Therapeutics Inc.

ImmuneOncia was established as a joint venture between Sorrento Therapeutics, USA and Yuhan Corporation, Korea, focusing on immuno-oncology and aims to bring safe, effective immunotherapies to patients worldwide.

Therapeutic Areas

Oncology

Technologies

Other

Company Type

Pharmaceutical

State of Ownership

Private

Sponsorship Group

Networker

Influencer Of

Topics

Editions participated in:

September 2017 March 2018 March 2019